Pierre-Francois Plouin Selected Research

Aldosterone

3/2015	Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
4/2013	Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.
9/2004	Would wider screening for primary aldosteronism give any health benefits?
1/2002	[Angiotensin II receptor blockers: current status and future prospects].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre-Francois Plouin Research Topics

Disease

3	Adenoma (Adenomas) 03/2015 - 09/2004
3	Hypertension (High Blood Pressure) 04/2013 - 01/2002
2	Hyperaldosteronism (Conn Syndrome) 03/2015 - 09/2004
2	Pheochromocytoma 12/2014 - 10/2013
1	Neoplasms (Cancer) 12/2014
1	Rupture 12/2014
1	Paraganglioma (Paragangliomas) 10/2013
1	Renal Insufficiency (Renal Failure) 01/2002
1	Cough 01/2002
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2002
1	Fibrosis (Cirrhosis) 01/2002
1	Inflammation (Inflammations) 01/2002
1	Myocardial Infarction 01/2002
1	Proteinuria 01/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2002

Drug/Important Bio-Agent (IBA)

4	AldosteroneIBA 03/2015 - 01/2002
2	ReninIBA 09/2004 - 01/2002
1	Mineralocorticoid Receptor AntagonistsIBA 03/2015
1	PotassiumIBA 03/2015
1	Capsules (Microcapsules)IBA 12/2014
1	Adenosine Triphosphatases (ATPase)IBA 04/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2002
1	AngiotensinsIBA 01/2002
1	Pharmaceutical PreparationsIBA 01/2002
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2002

Therapy/Procedure

1	Therapeutics 10/2013
1	Adrenalectomy 09/2004